Sign in
Taking people in United StatesNo phase

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

Key facts

Who runs it
University of Rochester
Where
Rochester, United StatesSee the site
Trial code
Status
Recruiting
People taking part
408 people, planned
Started
17 Jun 2025
Expected to end
31 May 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Actívatexto
  • Decídetexto
Record updated
18 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Self-identify as Hispanic and/or Latino
  • Know how to read and speak English and/or Spanish
  • Be ≥ 18 years of age
  • Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity)
  • Smoke cigarettes at least 3 days per week
  • Be interested in quitting smoking in the next 30 days
  • Have a cellphone with text messaging capability
  • Know how to utilize text messages
  • Be willing to wear a wearable device daily to monitor physical activity
  • Be willing to complete all study visits

Who cannot take part

  • Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes)
  • Being pregnant or breastfeeding
  • Plan to move from their current residence in the next six months
  • Another household member enrolled in the study
  • Unable to become more physically active or engage in a fitness appraisal

Where in United States

  • University of Rochester Medical CenterRochester, United StatesContact: Francisco Cartujano, MDTaking people

About the trial

What the trial wants to find out

The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy [i.e., nicotine replacement therapies (NRT)], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

The 2 groups in the trial

  • ActívatextoTreatment being tested

    Actívatexto is a mobile intervention that promotes both smoking cessation and physical activity. Actívatexto integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

  • DecídetextoExisting treatment, for comparison

    Decídetexto is a mobile intervention that solely promotes smoking cessation. Decídetexto integrates three components: 1) a text messaging program that solely promotes smoking cessation, 2) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 3) an online dashboard where the research team manages participants' incoming and outgoing data from the text messaging program.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
18 September 2026